Quality of life of patients treated with opium tincture or methadone: A randomized controlled trial

• Published in: Drug and alcohol dependence 2023-08, Vol.249, p.110874-110874, Article 110874
• Main Authors: Kim, Jane J., Nikoo, Mohammadali, Nikoo, Nooshin, Javidanbardan, Sanam, Kazemi, Alireza, Choi, Fiona, Gholami, Ali, Lafooraki, Neda Y., Vogel, Marc, Rezazadeh-Azar, Pouya, Meyer, Maximilian, Cabanis, Maurice, Jang, Kerry, Aknondzadeh, Shahin, Krausz, Michael
• Format: Article
• Language: English
• Subjects: Iran; Methadone; Opioid agonist treatment; Opioid use disorder; Opium tincture; Quality of life
• ISSN: 0376-8716; 1879-0046
• DOI: 10.1016/j.drugalcdep.2023.110874

Quality of life (QoL) is an increasingly recognized patient-centered treatment outcome in individuals with opioid use disorder. There is a gap in literature on the impact of opium tincture (OT) on patients’ QoL compared to standard treatment options such as methadone. This study aimed to compare the QoL of participants with opioid use disorder receiving OAT using OT or methadone and identify the factors associated with their QoL during treatment. The opium trial was a multicenter non-inferiority randomized clinical trial in four private OAT outpatient clinics in Iran. The study assigned patients to either OT (10 mg/ml) or methadone sirup (5 mg/ml) for a follow-up of 85 days. QoL was assessed using the brief version of the World Health Organization Quality of Life instrument (WHOQOL- BREF). A total of 83 participants, 35 (42.2%) in the OT arm and 48 (57.8%) in the methadone arm, completed the WHOQOL-BREF in full and were included in the primary analysis. The mean score of patients’ QoL showed improvement compared to baseline, but differences were not statistically significant between OT and methadone arms (p = 0.786). Improvements were mainly observed within the first 30 days of receiving treatment. Being married and lower psychological distress were associated with an improved QoL. Within the social relationships domain, male gender showed significantly higher QoL compared to females. OT shows promise as an OAT medication, comparable to methadone in improving patients’ QoL. There is a need to incorporate psychosocial interventions to further sustain and improve the QoL in this population. Identifying other social determinants of health which affect QoL and the cultural adaptation of assessments for individuals from various ethnocultural backgrounds are critical areas of inquiry. •Treatment with opium tincture and methadone can improve patients’ quality of life.•Improvements were mainly observed within the first month of receiving treatment.•Integrating psychosocial interventions may improve patient outcomes.•Quality of life is an important measure in opioid use disorder treatment.